AMICUS THERAPEUTICS, INC. — Director's Dealing 2025

Feb 13, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AMICUS THERAPEUTICS, INC. (FOLD)
CIK: 0001178879
Period of Report: 2025-02-11

Reporting Person: Prout Samantha (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-02-11	Common Stock	A	27416	—	Acquired	122941	Direct
2025-02-11	Common Stock	F	13500	$9.57	Disposed	109441	Direct

Footnotes

F1: Granted for the achievement of the 2022 PRSUs as determined by the Board of Directors.